Mazlan, Mazlina and Engkasan, Julia Patrick (2022) Does pharmacological treatment of depression in people with a primary brain tumour bring any benefits? A Cochrane Review summary with commentary. Neurorehabilitation, 50 (4). pp. 501-503. ISSN 1053-8135, DOI https://doi.org/10.3233/NRE-228019.
Full text not available from this repository.Abstract
BACKGROUND: Persons with primary brain tumour can suffer from depression. Depression may hinder rehabilitation intervention leading to further deterioration of patient's health and functioning. OBJECTIVE: The Cochrane Review aimed to assess the effectiveness and adverse effects of pharmacological treatment of depression in people with a primary brain tumour. METHODS: A Cochrane Review by Beevers et al. was summarized with comments. RESULTS: The reviewdid not find any eligible studies from the 2090 studies screened which included randomized controlled trials, cohort studies and case-control studies. CONCLUSIONS: There is no high-quality evidence as to whether pharmacological treatments for depression in people with primary brain tumours are either effective or harmful.
| Item Type: | Article |
|---|---|
| Funders: | UNSPECIFIED |
| Uncontrolled Keywords: | Brain tumour; depression; medications; pharmacology |
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RS Pharmacy and materia medica |
| Divisions: | Faculty of Medicine > Rehabilitation Medicine Department |
| Depositing User: | Ms Zaharah Ramly |
| Date Deposited: | 09 Jul 2024 08:21 |
| Last Modified: | 09 Jul 2024 08:21 |
| URI: | http://eprints.um.edu.my/id/eprint/39604 |
Actions (login required)
 |
View Item |
